ESI-09

CAS: 263707-16-0

Ref. 3D-NKA70716

Informação sobre produto

• Nome: ESI-09
• Marca: Biosynth
• Descrição: ESI-09 is a novel drug candidate that has been shown to have synergistic effects with chemotherapeutic agents in the treatment of cancer. It is a potential drug target for cancer, and its anticancer activity may be due to its ability to reduce oxidative stress by activating antioxidant enzymes. ESI-09 has antioxidative properties and decreases the mitochondrial membrane potential, which leads to increased ATP levels. ESI-09 also has the ability to cause cell death by inhibiting aerobic glycolysis, which may be due to its inhibitory effects on the polymerase chain reaction (PCR).

Propriedades químicas

• Peso molecular: 330.77 g/mol
• Fórmula: C₁₆H₁₅ClN₄O₂
• Pureza: Min. 95%